Sarah Sandmann, Stefan Hegselmann, Michael Fujarski, Lucas Bickmann, Benjamin Wild, Roland Eils, Julian Varghese
{"title":"Benchmark evaluation of DeepSeek large language models in clinical decision-making","authors":"Sarah Sandmann, Stefan Hegselmann, Michael Fujarski, Lucas Bickmann, Benjamin Wild, Roland Eils, Julian Varghese","doi":"10.1038/s41591-025-03727-2","DOIUrl":null,"url":null,"abstract":"Large language models (LLMs) are increasingly transforming medical applications. However, proprietary models such as GPT-4o face significant barriers to clinical adoption because they cannot be deployed on site within healthcare institutions, making them noncompliant with stringent privacy regulations. Recent advancements in open-source LLMs such as DeepSeek models offer a promising alternative because they allow efficient fine-tuning on local data in hospitals with advanced information technology infrastructure. Here, to demonstrate the clinical utility of DeepSeek-V3 and DeepSeek-R1, we benchmarked their performance on clinical decision support tasks against proprietary LLMs, including GPT-4o and Gemini-2.0 Flash Thinking Experimental. Using 125 patient cases with sufficient statistical power, covering a broad range of frequent and rare diseases, we found that DeepSeek models perform equally well and in some cases better than proprietary LLMs. Our study demonstrates that open-source LLMs can provide a scalable pathway for secure model training enabling real-world medical applications in accordance with data privacy and healthcare regulations. In an evaluation involving 125 standardized patient cases, open-source DeepSeek large language models are shown to perform at least on par with state-of-the-art proprietary large language models in diagnosis and treatment recommendation tasks.","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"31 8","pages":"2546-2549"},"PeriodicalIF":50.0000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/s41591-025-03727-2.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41591-025-03727-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Large language models (LLMs) are increasingly transforming medical applications. However, proprietary models such as GPT-4o face significant barriers to clinical adoption because they cannot be deployed on site within healthcare institutions, making them noncompliant with stringent privacy regulations. Recent advancements in open-source LLMs such as DeepSeek models offer a promising alternative because they allow efficient fine-tuning on local data in hospitals with advanced information technology infrastructure. Here, to demonstrate the clinical utility of DeepSeek-V3 and DeepSeek-R1, we benchmarked their performance on clinical decision support tasks against proprietary LLMs, including GPT-4o and Gemini-2.0 Flash Thinking Experimental. Using 125 patient cases with sufficient statistical power, covering a broad range of frequent and rare diseases, we found that DeepSeek models perform equally well and in some cases better than proprietary LLMs. Our study demonstrates that open-source LLMs can provide a scalable pathway for secure model training enabling real-world medical applications in accordance with data privacy and healthcare regulations. In an evaluation involving 125 standardized patient cases, open-source DeepSeek large language models are shown to perform at least on par with state-of-the-art proprietary large language models in diagnosis and treatment recommendation tasks.
期刊介绍:
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors.
Nature Medicine consider all types of clinical research, including:
-Case-reports and small case series
-Clinical trials, whether phase 1, 2, 3 or 4
-Observational studies
-Meta-analyses
-Biomarker studies
-Public and global health studies
Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.